Global PD-L1 Biomarker Testing Platform Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 42463
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Services
Buy @ $3500

The PD-L1 Biomarker Testing Platform market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global PD-L1 Biomarker Testing Platform size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global PD-L1 Biomarker Testing Platform market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

PD-L1 Biomarker Testing Platform market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

PD-L1(22C3)

PD-L1(28-8)

PD-L1(SP142)

PD-L1(SP263)

Other

Market segment by Application, can be divided into

Hospital

Diagnostic Center

Other

Market segment by players, this report covers

Agilent Technologies

Roche

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of PD-L1 Biomarker Testing Platform

1.2 Classification of PD-L1 Biomarker Testing Platform by Type

1.2.1 Overview: Global PD-L1 Biomarker Testing Platform Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global PD-L1 Biomarker Testing Platform Revenue Market Share by Type in 2020

1.2.3 PD-L1(22C3)

1.2.4 PD-L1(28-8)

1.2.5 PD-L1(SP142)

1.2.6 PD-L1(SP263)

1.2.7 Other

1.3 Global PD-L1 Biomarker Testing Platform Market by Application

1.3.1 Overview: Global PD-L1 Biomarker Testing Platform Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Diagnostic Center

1.3.4 Other

1.4 Global PD-L1 Biomarker Testing Platform Market Size & Forecast

1.5 Global PD-L1 Biomarker Testing Platform Market Size and Forecast by Region

1.5.1 Global PD-L1 Biomarker Testing Platform Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global PD-L1 Biomarker Testing Platform Market Size by Region, (2016-2021)

1.5.3 North America PD-L1 Biomarker Testing Platform Market Size and Prospect (2016-2026)

1.5.4 Europe PD-L1 Biomarker Testing Platform Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific PD-L1 Biomarker Testing Platform Market Size and Prospect (2016-2026)

1.5.6 South America PD-L1 Biomarker Testing Platform Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa PD-L1 Biomarker Testing Platform Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 PD-L1 Biomarker Testing Platform Market Drivers

1.6.2 PD-L1 Biomarker Testing Platform Market Restraints

1.6.3 PD-L1 Biomarker Testing Platform Trends Analysis

2 Company Profiles

2.1 Agilent Technologies

2.1.1 Agilent Technologies Details

2.1.2 Agilent Technologies Major Business

2.1.3 Agilent Technologies PD-L1 Biomarker Testing Platform Product and Solutions

2.1.4 Agilent Technologies PD-L1 Biomarker Testing Platform Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Agilent Technologies Recent Developments and Future Plans

2.2 Roche

2.2.1 Roche Details

2.2.2 Roche Major Business

2.2.3 Roche PD-L1 Biomarker Testing Platform Product and Solutions

2.2.4 Roche PD-L1 Biomarker Testing Platform Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Roche Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global PD-L1 Biomarker Testing Platform Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 PD-L1 Biomarker Testing Platform Players Market Share

3.2.2 Top 10 PD-L1 Biomarker Testing Platform Players Market Share

3.2.3 Market Competition Trend

3.3 PD-L1 Biomarker Testing Platform Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global PD-L1 Biomarker Testing Platform Revenue and Market Share by Type (2016-2021)

4.2 Global PD-L1 Biomarker Testing Platform Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global PD-L1 Biomarker Testing Platform Revenue Market Share by Application (2016-2021)

5.2 PD-L1 Biomarker Testing Platform Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America PD-L1 Biomarker Testing Platform Revenue by Type (2016-2026)

6.2 North America PD-L1 Biomarker Testing Platform Revenue by Application (2016-2026)

6.3 North America PD-L1 Biomarker Testing Platform Market Size by Country

6.3.1 North America PD-L1 Biomarker Testing Platform Revenue by Country (2016-2026)

6.3.2 United States PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

6.3.3 Canada PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

6.3.4 Mexico PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe PD-L1 Biomarker Testing Platform Revenue by Type (2016-2026)

7.2 Europe PD-L1 Biomarker Testing Platform Revenue by Application (2016-2026)

7.3 Europe PD-L1 Biomarker Testing Platform Market Size by Country

7.3.1 Europe PD-L1 Biomarker Testing Platform Revenue by Country (2016-2026)

7.3.2 Germany PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

7.3.3 France PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

7.3.4 United Kingdom PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

7.3.5 Russia PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

7.3.6 Italy PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific PD-L1 Biomarker Testing Platform Revenue by Type (2016-2026)

8.2 Asia-Pacific PD-L1 Biomarker Testing Platform Revenue by Application (2016-2026)

8.3 Asia-Pacific PD-L1 Biomarker Testing Platform Market Size by Region

8.3.1 Asia-Pacific PD-L1 Biomarker Testing Platform Revenue by Region (2016-2026)

8.3.2 China PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

8.3.3 Japan PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

8.3.4 South Korea PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

8.3.5 India PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

8.3.7 Australia PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America PD-L1 Biomarker Testing Platform Revenue by Type (2016-2026)

9.2 South America PD-L1 Biomarker Testing Platform Revenue by Application (2016-2026)

9.3 South America PD-L1 Biomarker Testing Platform Market Size by Country

9.3.1 South America PD-L1 Biomarker Testing Platform Revenue by Country (2016-2026)

9.3.2 Brazil PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

9.3.3 Argentina PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa PD-L1 Biomarker Testing Platform Revenue by Type (2016-2026)

10.2 Middle East & Africa PD-L1 Biomarker Testing Platform Revenue by Application (2016-2026)

10.3 Middle East & Africa PD-L1 Biomarker Testing Platform Market Size by Country

10.3.1 Middle East & Africa PD-L1 Biomarker Testing Platform Revenue by Country (2016-2026)

10.3.2 Turkey PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

10.3.4 UAE PD-L1 Biomarker Testing Platform Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global PD-L1 Biomarker Testing Platform Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global PD-L1 Biomarker Testing Platform Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market PD-L1 Biomarker Testing Platform Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global PD-L1 Biomarker Testing Platform Revenue (USD Million) by Region (2016-2021)

Table 5. Global PD-L1 Biomarker Testing Platform Revenue Market Share by Region (2021-2026)

Table 6. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 7. Agilent Technologies Major Business

Table 8. Agilent Technologies PD-L1 Biomarker Testing Platform Product and Solutions

Table 9. Agilent Technologies PD-L1 Biomarker Testing Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Roche Corporate Information, Head Office, and Major Competitors

Table 11. Roche Major Business

Table 12. Roche PD-L1 Biomarker Testing Platform Product and Solutions

Table 13. Roche PD-L1 Biomarker Testing Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Global PD-L1 Biomarker Testing Platform Revenue (USD Million) by Players (2019-2021)

Table 15. Global PD-L1 Biomarker Testing Platform Revenue Share by Players (2019-2021)

Table 16. Breakdown of PD-L1 Biomarker Testing Platform by Company Type (Tier 1, Tier 2 and Tier 3)

Table 17. PD-L1 Biomarker Testing Platform Players Head Office, Products and Services Provided

Table 18. PD-L1 Biomarker Testing Platform Mergers & Acquisitions in the Past Five Years

Table 19. PD-L1 Biomarker Testing Platform New Entrants and Expansion Plans

Table 20. Global PD-L1 Biomarker Testing Platform Revenue (USD Million) by Type (2016-2021)

Table 21. Global PD-L1 Biomarker Testing Platform Revenue Share by Type (2016-2021)

Table 22. Global PD-L1 Biomarker Testing Platform Revenue Forecast by Type (2021-2026)

Table 23. Global PD-L1 Biomarker Testing Platform Revenue by Application (2016-2021)

Table 24. Global PD-L1 Biomarker Testing Platform Revenue Forecast by Application (2021-2026)

Table 25. North America PD-L1 Biomarker Testing Platform Revenue by Type (2016-2021) & (USD Million)

Table 26. North America PD-L1 Biomarker Testing Platform Revenue by Type (2021-2026) & (USD Million)

Table 27. North America PD-L1 Biomarker Testing Platform Revenue by Application (2016-2021) & (USD Million)

Table 28. North America PD-L1 Biomarker Testing Platform Revenue by Application (2021-2026) & (USD Million)

Table 29. North America PD-L1 Biomarker Testing Platform Revenue by Country (2016-2021) & (USD Million)

Table 30. North America PD-L1 Biomarker Testing Platform Revenue by Country (2021-2026) & (USD Million)

Table 31. Europe PD-L1 Biomarker Testing Platform Revenue by Type (2016-2021) & (USD Million)

Table 32. Europe PD-L1 Biomarker Testing Platform Revenue by Type (2021-2026) & (USD Million)

Table 33. Europe PD-L1 Biomarker Testing Platform Revenue by Application (2016-2021) & (USD Million)

Table 34. Europe PD-L1 Biomarker Testing Platform Revenue by Application (2021-2026) & (USD Million)

Table 35. Europe PD-L1 Biomarker Testing Platform Revenue by Country (2016-2021) & (USD Million)

Table 36. Europe PD-L1 Biomarker Testing Platform Revenue by Country (2021-2026) & (USD Million)

Table 37. Asia-Pacific PD-L1 Biomarker Testing Platform Revenue by Type (2016-2021) & (USD Million)

Table 38. Asia-Pacific PD-L1 Biomarker Testing Platform Revenue by Type (2021-2026) & (USD Million)

Table 39. Asia-Pacific PD-L1 Biomarker Testing Platform Revenue by Application (2016-2021) & (USD Million)

Table 40. Asia-Pacific PD-L1 Biomarker Testing Platform Revenue by Application (2021-2026) & (USD Million)

Table 41. Asia-Pacific PD-L1 Biomarker Testing Platform Revenue by Region (2016-2021) & (USD Million)

Table 42. Asia-Pacific PD-L1 Biomarker Testing Platform Revenue by Region (2021-2026) & (USD Million)

Table 43. South America PD-L1 Biomarker Testing Platform Revenue by Type (2016-2021) & (USD Million)

Table 44. South America PD-L1 Biomarker Testing Platform Revenue by Type (2021-2026) & (USD Million)

Table 45. South America PD-L1 Biomarker Testing Platform Revenue by Application (2016-2021) & (USD Million)

Table 46. South America PD-L1 Biomarker Testing Platform Revenue by Application (2021-2026) & (USD Million)

Table 47. South America PD-L1 Biomarker Testing Platform Revenue by Country (2016-2021) & (USD Million)

Table 48. South America PD-L1 Biomarker Testing Platform Revenue by Country (2021-2026) & (USD Million)

Table 49. Middle East & Africa PD-L1 Biomarker Testing Platform Revenue by Type (2016-2021) & (USD Million)

Table 50. Middle East & Africa PD-L1 Biomarker Testing Platform Revenue by Type (2021-2026) & (USD Million)

Table 51. Middle East & Africa PD-L1 Biomarker Testing Platform Revenue by Application (2016-2021) & (USD Million)

Table 52. Middle East & Africa PD-L1 Biomarker Testing Platform Revenue by Application (2021-2026) & (USD Million)

Table 53. Middle East & Africa PD-L1 Biomarker Testing Platform Revenue by Country (2016-2021) & (USD Million)

Table 54. Middle East & Africa PD-L1 Biomarker Testing Platform Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. PD-L1 Biomarker Testing Platform Picture

Figure 2. Global PD-L1 Biomarker Testing Platform Revenue Market Share by Type in 2020

Figure 3. PD-L1(22C3)

Figure 4. PD-L1(28-8)

Figure 5. PD-L1(SP142)

Figure 6. PD-L1(SP263)

Figure 7. Other

Figure 8. PD-L1 Biomarker Testing Platform Revenue Market Share by Application in 2020

Figure 9. Hospital Picture

Figure 10. Diagnostic Center Picture

Figure 11. Other Picture

Figure 12. Global PD-L1 Biomarker Testing Platform Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global PD-L1 Biomarker Testing Platform Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global PD-L1 Biomarker Testing Platform Revenue Market Share by Region (2016-2026)

Figure 15. Global PD-L1 Biomarker Testing Platform Revenue Market Share by Region in 2020

Figure 16. North America PD-L1 Biomarker Testing Platform Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe PD-L1 Biomarker Testing Platform Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific PD-L1 Biomarker Testing Platform Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America PD-L1 Biomarker Testing Platform Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa PD-L1 Biomarker Testing Platform Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. PD-L1 Biomarker Testing Platform Market Drivers

Figure 22. PD-L1 Biomarker Testing Platform Market Restraints

Figure 23. PD-L1 Biomarker Testing Platform Market Trends

Figure 24. Agilent Technologies Recent Developments and Future Plans

Figure 25. Roche Recent Developments and Future Plans

Figure 26. Global PD-L1 Biomarker Testing Platform Revenue Share by Players in 2020

Figure 27. PD-L1 Biomarker Testing Platform Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 28. Global Top 3 Players PD-L1 Biomarker Testing Platform Revenue Market Share in 2020

Figure 29. Global Top 10 Players PD-L1 Biomarker Testing Platform Revenue Market Share in 2020

Figure 30. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 31. Global PD-L1 Biomarker Testing Platform Revenue Share by Type in 2020

Figure 32. Global PD-L1 Biomarker Testing Platform Market Share Forecast by Type (2021-2026)

Figure 33. Global PD-L1 Biomarker Testing Platform Revenue Share by Application in 2020

Figure 34. Global PD-L1 Biomarker Testing Platform Market Share Forecast by Application (2021-2026)

Figure 35. North America PD-L1 Biomarker Testing Platform Sales Market Share by Type (2016-2026)

Figure 36. North America PD-L1 Biomarker Testing Platform Sales Market Share by Application (2016-2026)

Figure 37. North America PD-L1 Biomarker Testing Platform Revenue Market Share by Country (2016-2026)

Figure 38. United States PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 39. Canada PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 40. Mexico PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Europe PD-L1 Biomarker Testing Platform Sales Market Share by Type (2016-2026)

Figure 42. Europe PD-L1 Biomarker Testing Platform Sales Market Share by Application (2016-2026)

Figure 43. Europe PD-L1 Biomarker Testing Platform Revenue Market Share by Country (2016-2026)

Figure 44. Germany PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. France PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. United Kingdom PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Russia PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Italy PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Asia-Pacific PD-L1 Biomarker Testing Platform Sales Market Share by Type (2016-2026)

Figure 50. Asia-Pacific PD-L1 Biomarker Testing Platform Sales Market Share by Application (2016-2026)

Figure 51. Asia-Pacific PD-L1 Biomarker Testing Platform Revenue Market Share by Region (2016-2026)

Figure 52. China PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Japan PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. South Korea PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. India PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Southeast Asia PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Australia PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. South America PD-L1 Biomarker Testing Platform Sales Market Share by Type (2016-2026)

Figure 59. South America PD-L1 Biomarker Testing Platform Sales Market Share by Application (2016-2026)

Figure 60. South America PD-L1 Biomarker Testing Platform Revenue Market Share by Country (2016-2026)

Figure 61. Brazil PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Argentina PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Middle East and Africa PD-L1 Biomarker Testing Platform Sales Market Share by Type (2016-2026)

Figure 64. Middle East and Africa PD-L1 Biomarker Testing Platform Sales Market Share by Application (2016-2026)

Figure 65. Middle East and Africa PD-L1 Biomarker Testing Platform Revenue Market Share by Country (2016-2026)

Figure 66. Turkey PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Saudi Arabia PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. UAE PD-L1 Biomarker Testing Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Methodology

Figure 70. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz